Johnson & Johnson settles opioid case with New York for $230 million

Pharmaceutical company Johnson & Johnson will pay $230 million to settle an opioid lawsuit with the state of New York, the state’s attorney general said Saturday.

According to a release from New York AG Letitia James, Johnson & Johnson “has committed to ending the manufacture and sale of all opioids and opioid products for distribution in the state of New York, as well as to no longer ship these products anywhere within the United States.”

The company said in a statement Saturday that it “made the business decision in 2020 to discontinue all of its prescription pain medications in the United States.” The settlement removes Johnson & Johnson from a trial scheduled to begin in New York on Tuesday, but not from other cases across the US,...

Continue reading…